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Abstract     
An efficient high-throughput synthesis of 4-aryl substituted 1,4,5,6-tetrahydro-2-methyl-6-
thioxopyridine-3-carboxylates 5a-p was developed by using Lawesson’s reagent, a very effective 
thionating reagent for carbonyl compounds, under conventional conditions and microwave 
irradiation. In order to gain a better understanding of the structure of the heterocycles obtained, 
theoretical calculations at the ab initio level were carried out. 
 




Introduction    
 
The importance of sulfur-containing heterocyclic compounds for biomedical1 and material 
science applications2 has led to an increase in the number of synthetic methods available for the 
preparation of this type of heterocyclic compounds.3,4 In particular, thioxo derivatives of 1,4-
dihydropyridines have attracted attention as reactive compounds with cardiovascular activity.5 
Also 2-alkylthio-1,4-dihydropyridine derivatives present hepatoprotective6 and anti-oxidant 
activity.7 
The preparation of the 3,4-dihydropyridine-2(1H)-thione ring is a challenge in organic 
synthesis. The usual procedure for the synthesis of these derivatives is a modification of 
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Hantzsch route; however, this approach has several serious drawbacks, such as low catalyst life 
cycle, side reactions, unsatisfactory yield, high temperatures, and long reaction 
times.3,8Therefore, we searched for milder, more convenient and efficient methods for the 
preparation of these heterocyclic derivatives.  
In this regard, we took advantage of new technologies for high-throughput synthesis, which 
have been promoted by the demand for structurally diverse compound libraries for screening in 
lead discovery.9 One of these high-speed techniques is microwave-assisted organic synthesis, 
which has attracted a substantial amount of attention in recent years since the first reports by 
Gedye10 and Giguere11 in 1986. The main benefits of performing reactions under microwave 
irradiation conditions are the significant rate-enhancements and the higher product yields.12 Not 
surprisingly, these features have recently attracted the interest in drug discovery and medical 
chemistry communities,13,14 for which reaction efficiency and speed is of maximum importance. 
Although the exact reasons why microwave irradiation is able to enhance chemical processes are 
still unknown, many research works have been recently contribute, to obtain a definitive answer 
about the existence or nonexistence of the “specific effects” of microwave irradiation in a 
chemical reaction. 15 
As part of our studies addressing the synthesis of 1,4-dihydropyridine derivatives with 
substitution patterns required for a biological chemical programme,14 and in order to improve the 
methods to obtain them, we synthesized a new series of 4-aryl substituted 1,4,5,6-tetrahydro-2-
methyl-6-thioxopyridine-3-carboxylates 5a-p from 4-aryl substituted 1,4,5,6-tetrahydro-2-
methyl-6-oxopyridine-3-carboxylates 4a-p by using  Lawesson’s reagent (LR= 2,4-bis (4-
methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulphide) under microwave irradiation. 
These results were compared with those obtained by conventional heating.  
Lawesson’s reagent has been widely used as a powerful, mild, and versatile reagent for 
transforming carbonyl into thiocarbonyl groups.16 The key issue here is the chemoselectivity of  
LR observed when a nucleophilic centre, other than a carbonyl group, is present in the 
molecule.17 The functionalized molecules 5 are building blocks of interest for further chemical 
transformations. 
 
Results and Discussion    
 
The synthesis of 4-aryl substituted alkyl 2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-
carboxylates 5a-p was performed in a one-step procedure by thionation of the alkyl 2-methyl 6-
oxo-1,4,5,6-tetrahydropyridine-3-carboxylates 4a-p. The intermediates 4a-p were prepared 
following a procedure previously reported by our group.18 Thus, equimolecular amounts of 
starting compounds 1, 2 and 3 in ammonium acetate (see Scheme 1) were placed in a microwave 
monomode reactor (CEM Discover) in a cylindrical Pyrex vessel and irradiated at a controlled 
temperature (100 ºC) for 10 min. When the irradiation was stopped, the solids were treated with 
ethyl acetate and filtered to give the pure products 4a-p in good yields (83 – 95 %).  
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Since it has been reported that LR decomposes over 60-70 ºC,19 the conventional thionation 
of compounds 4a-p using the LR was accomplished by heating in dry toluene at 60 ºC (Method 
A, see Scheme 1). 4-Aryl substituted alkyl 2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-
carboxylates 5a-p, were obtained as yellow crystals in moderate yields, after purification from 
ethanol. Table 1 shows the main data for the synthesis of compounds 5a-p. An increase in the 




Scheme 1. Synthesis of compounds 5a-p. Method A: conventional heating (60-70ºC), toluene, 4 
hr; Method B: MW (60ºC, 250W), without solvent, 8 min; Method C: MW (60ºC, 250W), 
xylene (2mL), 10 min. 
 
It has been reported that LR gives an efficient conversion of carbonyl functionalities into 
their thio analogues, mixing the carbonyl substrates with Lawesson’s reagent followed by 
exposure to microwave irradiation under no-solvent conditions.20 Following this methodology, 
equimolecular amounts of starting compound 4 and LR were placed in a microwave monomode 
reactor (CEM Discover) in a cylindrical Pyrex vessel and were irradiated, under temperature 
control protocol at 60 ºC and a maximum power of 250W (Method B. See Scheme 1 and Table 
1). Unexpectedly, when the reaction was carried out under solvent-free conditions (Method B), 5 
were obtained in low or moderate yields.  
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Table 1. Comparison between the conventional procedure (Method A) and microwave 
irradiation Methods B and C) for the synthesis of compounds 5a-o 





(%) 5a CH3 H A Toluene 240 60 70 
B None 8 60 35 
C Xylene 10 60 82 
5b CH3 2-Cl A Toluene 240 60 72 
B None 8 60 38 
C Xylene 10 60 90 
5c CH3 2,4-diCl A Toluene 240 60 58 
5d CH3 2-NO2 A Toluene 240 60 74 
B None 8 60 42 
C Xylene 10 60 91 
5e CH3 3-OCH3 A Toluene 240 60 78 
5f CH3 4-COOCH3 A Toluene 240 60 81 
B None 8 60 39 
C Xylene 10 60 92 
5g CH2CH3 H A Toluene 240 60 68 
B None 8 60 30 
C Xylene 10 60 87 
5h CH2CH3 2-Cl A Toluene 240 60 75 
B None 8 60 29 
C Xylene 10 60 89 
5i CH2CH3 2,4-diCl A Toluene 240 60 77 
5j CH2CH3 2-NO2 A Toluene 240 60 72 
5k CH2CH3 3-NO2 A Toluene 240 60 72 
B None 8 60 32 
C Xylene 10 60 91 
5l CH2CH3 4-NO2 A Toluene 240 60 82 
B None 8 60 36 
C Xylene 10 60 93 
5m CH2CH3 3-OCH3 A Toluene 240 60 81 
B None 8 60 39 
C Xylene 10 60 90 
5n CH2CH3 4-OCH3 A Toluene 240 60 76 
5o CH2CH3 4-COOCH3 A Toluene 240 60 74 
B None 8 60 39 
   C Xylene 10 60 88 
5p CH2CH3 F5 A Toluene 240 60 64 
B None 8 60 35 
C Xylene 10 60 87 
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Taking into account that to increase the efficiency of the MW assisted synthesis the reaction 
requires, preferably, at least one liquid phase in the heterogeneous media to produce an 
interfacial reaction, these results can be attributed to the poor homogeneity of the reaction 
medium, since derivatives 4 have melting points above 100 ºC and the reaction must occur at 60 
ºC to avoid decomposition of LR. 
In order to increase the efficiency of the thionation reaction, the reactions were carried out in 
the same conditions but by using xylene (2 mL) as solvent (Method C). The mixtures were 
irradiated with the same MW protocol at 60 ºC under continuous stirring for 10 minutes. In these 
conditions the 6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylates 5 were obtained in excellent 
yields (see Table 1). Xylene is a non-polar solvent widely used to observe some MW effects 
provided that it is transparent to MW and, consequently, it allows specific interactions with 
reaction partners. Also when the reaction is carried out in the presence of small amount of 
xylene, dissociation of LR into dithiophosphine 6 (see Scheme 2) is favored, which could explain 
the high yield of the products. 
All reactions were monitored by TLC and the experiments were replicated in order to ensure 
reproducibility. A maximum power setting of 250 W was found to be the best balance between 
efficiency and safety. 
To show the advantages of the microwave heating mode and to check the possibility of 
intervening with the specific non-purely thermal effects of microwaves, the reactions were 
performed by heating in a thermostated oil bath under the same experimental conditions used for 
microwave irradiation (time: 8 min. without solvent and 10 min. with xylene; temperature 60 oC, 
profiles of rise in temperature, vessels). In all cases, no reaction was detected by tlc, thus again 
supporting that the effect of microwave irradiation is not solely thermal. 
The experimental findings suggest that the improvement achieved with Method C [MW 
(Temperature control: 60 ºC/Max. Power: 250 W)/xylene (2 mL)] was due to a strong MW 
effect, related to the reaction mechanism and to the evolution of polarity during the course of the 
reaction. 
Taking into account previous reports using different substrates,17b,17c Scheme 2 shows the 
proposed mechanism for obtaining compound 5. LR is in equilibrium with a highly reactive 
dithiophosphine ylide 6 that reacts with 4 to form the thiaoxaphosphetane derivatives 8, which 
decompose as in a Wittig-analogue reaction21 to the corresponding 6-thioxo-1,4,5,6-
tetrahydropyridine derivatives 5. 
In the proposed mechanism, we can observe that the polarity of the system is enhanced 
during the course of the reaction since, for example, one of the intermediates 7 is charged. We 
should expect a decrease in the energy of activation under microwave irradiation as a result of 
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Scheme 2. Plausible mechanism for the formation of thiopyridones 5a-p. 
 
6-Thioxo-1,4,5,6-tetrahydropyridine compounds 5 were fully characterized by their 
analytical and spectroscopical data. NMR experiments confirmed the formation of these 
derivatives. Their spectroscopic data were very similar to those of the previously reported 
pyridone ring intermediates 4.23  
The 1H NMR spectra at 400 MHz show, in general, the presence of the NH group as a singlet 
at 8.9-9.2 ppm; the ABX system corresponding to the three protons of the thiopyridone ring, H4, 
H5a and H5b appear at 4.18-4.68 ppm, 3.02-3.37 ppm, and 2.76-3.19 ppm, respectively. In all 
cases, the methyl group on C-2 appeared as a singlet at δ 2.5 ppm. The 13C NMR spectra for the 
thiopyridone ring showed two quaternary carbon signals C-2 and C-3 at δ 150 ppm and δ 110 
ppm respectively, one tertiary carbon signal C-4 at δ 37 ppm, and one secondary carbon signal 
C-5 at δ 45 ppm. The carbonyl groups on C-3 appeared at 165.2-167.0 ppm. The main difference 
between 5 and its oxo-analogous 4 was found in the 13C NMR spectra for the signals of C-5 and 
C-6 atoms. The methylene signal corresponding to C-5 for derivatives 4 appeared at 36-39 ppm, 
whereas this signal appeared at 43-46 ppm for the thioxo derivates 5 as a result of the 
deshielding effect of the thiocarbonyl group present in the ring. The C=O signal corresponding to 
the C-6 of the 6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate 4 appeared at δ 169 ppm, and the 
C=S signal of the thioxopyridine derivatives 5 appeared at a higher δ value (δ 200 ppm).  
We have previously reported the mass spectra of pyridones 4 under EI conditions,24 and 
found that the base peaks are formed by the loss of the alkoxycarbonyl group. Thioxopyridone 
derivatives 5 underwent the same main fragmentation, thereby revealing that the sulfur atom 
does not induce changes in the fragmentation pattern. 
In order to gain a better understanding of the novel compounds and to analyze the influence 
that the change of a carbonyl group to a thiocarbonyl group has on the molecular geometry of the 
heterocyclic ring, we carried out ab-initio quantum chemical calculations at MP2/6-31G** level 
for compounds 4g and 5g. The geometrical features predicted are listed in Table 2, which shows 
the most relevant bond distances, valence angles, and dihedral angles.  
For both molecules, MP2 predicted that the heterocyclic ring presents a twisted boat 
conformation with the phenyl group in a pseudoaxial position and nearly orthogonal to the mean 
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plane of the heterocycle (See dihedral angles C2´-C1´-C4-C3 and C2´-C1´-C4-C5). This result is 
consistent with the X-ray structure of 4a previously reported.25 However, it is important to note 
some differences between compounds 4g and 5g. As expected, the bond distance C6-X increased 
in going from the carbonyl group (C6=O = 1.2261 Å) to the thiocarbonyl (C6=S = 1.638 Å), 
which caused the bond distances C2-N1 and C6-N1 in 5g to be smaller. 
The main difference between the two structures is the dihedral angle C4-C5-C6-X; in 4g, it 
has a negative value (-174.11°) and in 5g a positive value (140.99°), thereby indicating distinct 
orientations with respect to the plane that defines C4-C5-C6. 
A relevant factor related to the pharmacological activity of the biologically active 1,4-
dihydropyridines and related compounds is the geometry and orientation of the carbonyl group in 
the alkoxycarbonyl substituent on C3.26 In previous papers, we reported that the ester group on 
C3 in compounds 4 is coplanar with the endocyclic double bond, with a carbonyl group in a cis 
disposition. Theoretical calculations showed the same behavior for the novel compound 5g, with 
only minimal deviation of the dihedral angle C2-C3-C7-O7 (11.15°).  
These results indicate that the geometrical features of compounds 5 are quite similar to 
structurally related 1,4-dihydropyridines and, therefore, they exhibit appropriate structural 
features to act as potential calcium channel modulators.27 
 
Table 2. Most relevant bond distances, bond angles and dihedral angles for the most stable 
conformation of compounds 4g and 5g. Distances are given in Å and angles in degrees 
 4g 5g 
Bond distances (Å)   
N1-C2 1.397 1.361 
C2-C3 1.361 1.361 
C3-C4 1.513 1.511 
C4-C5 1.535 1.535 
C5-C6 1.506 1.502 
C6-N1 1.387 1.368 
C4-C1´ 1.516 1.514 
C6-Xa 1.226 1.638 
Bond angles (degrees)   
C2-N1-C6 126.23 126.50 
C3-C4-C5 110.30 109.85 
C5-C4-C1´ 112.08 112.49 
Dihedral angles (degrees)   
C4-C3-C2-N1 2.89 1.88 
C4-C5-C6-N1 -39.63 -42.54 
C2-N1-C6-C5 10.57 13.08 
C6-N1-C2-C3 8.98 8.41 
C3-C4-C5-C6 49.14 50.64 
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Table 2. Continued 
 4g 5g 
C5-C4-C3-C2 -31.26 -30.62 
C1´-C4-C3-C2 94.44 95.24 
C1´-C4-C5-C6 -76.60 -75.03 
C2-N1-C6-X -173.36 -170.33 
C4-C5-C6-X -174.11 140.99 
C2-C3-C7-O7 11.99 11.15 
C2´-C1´-C4-C3 137.24 135.37 
C2´-C1´-C4-C5 -98.04 -100.00 
 
To explain the selectivity of the thionation reaction, we analyzed the data obtained from the 
quantum-chemical calculations at MP2/6-31G** level. The reaction of 4 with dithiophosphine 
ylide 6 could take place either on O6 and/or O7. Figure 1 shows the most stable conformations 
calculated for compounds 5g, and 9 where the reaction occurs on O7. 
 
 
   
5g       9 
 
Figure 1. Ab initio (MP2/6-31G**) optimized geometry for compounds 5g and 9. 
 
The experimental results showed that the attack occurs solely on O6 of the 4-aryl substituted 
1,4,5,6-tetrahydro-2-methyl-6-oxopyridine-3-carboxylates 4, and no reaction is observed on O7. 
The regioselectivity of this reaction could be influenced by the following: i) the different charge 
of the oxygen atoms; ii) the geometrical accessibility of the reactive dithiophosphine ylide 6 to 
the oxygen atoms of molecule 4; and iii) the energy of the two possible products 5 and 9.  
The charges of the two oxygens atoms, O6 and O7, in compound 4 are very similar, -0.57 
and -0.61, respectively. In addition, although O6 is less sterically hindered than O7, because of 
the size and shape of 6 the reagent can access both sites. However, the energy of the two possible 
products 5 and 9 is very near: 741 917.03 and 741 910.76 kcal/mol, the first one is 6.27 kcal/mol 
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more stable than the second one. This finding could explain that only compounds 5 are obtained 
in the thionation reaction. 
 
 
Conclusions    
 
In summary, here we have carried out  a practical and efficient high-throughput synthesis of 
novel 4-aryl substituted alkyl 2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylates 5a-p 
from the readily available 4-aryl substituted alkyl 2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-
carboxylates 4a-p using LR, a very effective thionating reagent for carbonyl compounds, under a 
microwave-assisted optimized conditions. The best results were obtained under microwave 
conditions using xylene (2 mL) as solvent (Method C, 78-92%) to achieve a new, 
environmentally clean procedure (decrease in reaction time and amount of solvent used) for the 
synthesis of potential biologically active 6-thioxopyridines-3-carboxylate derivatives 5. These 
compounds are of interest as useful building blocks and as pharmacological compounds because 
they present the conformational features established as calcium channel modulators.  
  
 
Experimental Section     
 
General. Reagents and solvents were purchased from Fluka or Aldrich. 4-aryl substituted 
1,4,5,6-tetrahydro-2-methyl-6-oxopyridine-3-carboxylates 4 were synthesized according to a 
method reported in the literature [21] but using a domestic microwave oven (700 W, generating 
2450 MHz frequency) at a power of 280 W for 10 min at 72 ºC. The progress of the reaction and 
the purity of compounds were monitored by TLC analytical silica gel plates (Merck 60F250) 
using dichloromethane:methanol (8:2) as eluent. Melting points were determined in capillary 
tubes in an Electrothermal C14500 apparatus and are uncorrected. The NMR spectra were 
recorded on a Mercury 400 spectrometer [400 MHz (1H) and 75.4 (13C)]. Chemical shifts are 
given as δ values against tetramethylsilane as the internal standard and J values are given in Hz. 
Mass spectra were obtained in a LC/MSD-TOF(2006) Instrument (Agilent technologies). 
Microanalysis was performed in a Perkin-Elmer 2400 CHN. Ab initio calculations were carried 
out with the GAUSSIAN 98 program. Full geometry optimization and orbital analysis of 
compounds 4, 6 and the two possible products of the reaction 5 and 9 were performed at MP2 
level using the 6/31G** basis set.28 
 
General procedure for the microwave-assisted synthesis of 4-aryl substituted alkyl 1,4,5,6-
tetrahydro-2-methyl-6-oxopyridine-3-carboxylates (4) 
4-aryl substituted alkyl 1,4,5,6-tetrahydro-2-methyl-6-oxopyridine-3-carboxylates 4a-p were 
prepared following the procedure previously reported by us.21 In this case the MW irradiation 
was provided by a CEM Discover LabMate Focused Single Mode MW Synthesis Reactor, which 
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produced continuous stirring and irradiation with control of pressure and temperature. All these 
compounds were characterized by determination of physical constants and by NMR 
spectroscopy, which coincided with those previously reported for these compounds.17, 23 
 
General procedure for the conventional synthesis of 4-aryl substituted alkyl 1,4,5,6-
tetrahydro-2-methyl-6-thioxopyridine-3-carboxylates (5). (Method A) 
A mixture of appropriate 4-aryl substituted alkyl 2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-
carboxylates 4 (5 mmol) and LR (5mmol) in dry toluene was stirred and heated at controlled 
temperature (60-70 ºC). After 4 h, the reaction mixture was cooled to room temperature and 
filtered to remove white solid crystals. The toluene was removed in vacuo and the residue was 
precipitated by adding cool ether and filtered to afford the 4-aryl substituted alkyl 2-methyl-6-
thioxo-1,4,5,6-tetrahydropyridine-3-carboxylates 5 as yellow crystals. In some cases, further 
purification was accomplished by recrystalization from ethanol.  
 
General procedure for the microwave-assisted synthesis of 4-aryl substituted alkyl 1,4,5,6-
tetrahydro-2-methyl-6-thioxopyridine-3-carboxylates (5). (Method B and C) 
Method B. An equimolar mixture of the appropriate alkyl 4-aryl substituted-2-methyl-6-oxo-
1,4,5,6-tetrahydropyridine-3-carboxylates 4 (5 mmol) and LR (5mmol) were mixed thoroughly 
and irradiated in a CEM Discover LabMate Focused Single Mode MW Synthesis reactor at 250 
W for 8 min. The product was extracted with CHCl3. Excess solvent was removed in vacuo and 
the residue was precipitated by adding cool ether and filtered to afford the 4-aryl substituted 
alkyl 2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylates 5. 
Method C. An equimolar mixture of the appropriate 4-aryl substituted alkyl 2-methyl-6-oxo-
1,4,5,6-tetrahydropyridine-3-carboxylates 4 (5 mmol) and LR (5mmol) were dissolved in a 
minimum amount of xylene (2 mL) and irradiated in the CEM Discover reactor at 250 W for 10 
min. The reaction mixture was then cooled, the xylene was removed in vacuo and the residue 
was precipitated by adding cool ether and filtered to afford the 4-aryl substituted alkyl 2-methyl-
6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylates 5. 
Methyl 2-methyl-4-phenyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5a). Yield 
70% (Method A); 35% (Method B) and 82% (Method C); yellowish solid; mp 139-140 °C; 1H 
NMR (CDCl3) δ 2.44 (s, 3H, CH3), 3.10 (d, J = 16.2 Hz, B part of ABX, 1H, H5b), 3.38 (dd, J = 
16.2 Hz, J = 7.2 Hz, A part of ABX 1H, H5a), 3.68 (s, 3H, OCH3), 4.18 (d, J=7.2 Hz, X part of 
ABX, 1H, H4), 7.06-7.26 (m, 5H, Ph), 8.84 (br s, 1H, NH). 13C NMR (CDCl3) δ 19.2 (CH3-C2), 
37.5 (C4), 46.0 (C5), 61.0 (OCH3), 110.1 (C3), 126.4 (C4´), 128.2 (C3´), 126.8 (C2´, C6´), 128.6 
(C5´), 140.8 (C1´), 151.1 (C2), 166.4 (CO), 200.5 (C6); MS (m/z): 261 (M+), 229, 200, 199. 
Anal. Calcd for C14H15NO2S: C, 64.34; H, 5.79; N, 5.36. Found: C, 64.41; H, 5.72; N, 5.30. 
Methyl 4-(2’-chlorophenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5b). Yield 72% (Method A); 38% (Method B) and 90% (Method C); pale yellow solid; mp 110-
111 °C; 1H NMR (DMSO-d6) δ 8.94 (br s, 1H, NH), 7.49 (m, 1H, H3´), 7.28 (m, 2H, H4´, H5´), 
6.92 (m, 1H, H6´), 4.68 (d, J = 7.7 Hz, X part of ABX, 1H, H4), 4.01 (s, 3H, OCH3), 3.32 (dd, 
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16.3 Hz, J = 7.7 Hz, A part of ABX, 1H, H5a), 3.18 (d, J = 16.3 Hz, B part of ABX, 1H, H5b), 
2.36 (s, 3H, CH3); 
13C-NMR (DMSO-d6) δ 18.5 (CH3-C2), 34.6 (C4), 44.8 (C5), 60.8 (OCH3), 
110.1 (C3), 131.8 (C5´), 133.1 (C4´), 134.2 (C6´), 135.7 (C3´), 136.9 (C2´), 142.8 (C1´), 149.9 
(C2), 166.6 (CO), 200.9 (C6); MS (m/z): 295 (M+), 260. Anal. Calcd for C14H14ClNO2S: C, 
56.85; H, 4.77; N, 4.74. Found: C, 56.80; H, 4.81; N, 4.70. 
Methyl 4-(2’,4’-dichlorophenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-
carboxylate (5c). Yield 58% (Method A); pale yellow solid; mp 175-176 °C; 1H NMR (CDCl3) 
δ 2.18 (s, 3H, CH3), 2.92 (d, J = 16.3 Hz, B part of ABX, 1H, H5b), 3.20 (dd, J = 16.3 Hz, J = 
7.7 Hz, A part of ABX, 1H, H5a), 3.49 (s, 3H, OCH3), 4.43 (d, J = 7.7 Hz, X part of ABX, 1H, 
H4), 7.02 (m, 1H, H6´), 7.30 (m, 1H, H5´), 7.69 (m, 1H, H3´), 8.38 (br s, 1H, NH); 13C NMR 
(CDCl3) δ 18.3 (CH3-C2), 34.5 (C4), 43.1 (C5), 59.2 (OCH3), 102.9 (C3), 127.8 (C5´), 129.7 
(C6´), 131.2 (C3´), 134.2 (C4´), 136.5 (C2´), 141.6 (C1´), 150.2 (C2), 166.5 (CO), 200.3 (C6); 
MS (m/z): 329 (M+), 294. Anal. Calcd for C14H13Cl2NO2S: C, 50.92; H, 3.97; N, 4.24. Found: C, 
50.87; H, 3.94; N, 4.20. 
Methyl 2-methyl-4-(2’-nitrophenyl)-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5d). 
Yield 74% (Method A), 42% (Method B) and 91% (Method C); yellow solid; mp 159-160 °C; 
1H NMR (CDCl3) δ 2.32 (s, 3H, CH3), 2.78 (d, J = 16.6 Hz, B part of ABX, 1H, H5b), 3.22 (dd, 
J = 16.6 Hz, J = 8.5 Hz, A part of ABX, 1H, H5a), 3.98 (3H, s, OCH3), 4.47 (1H, d, H4, J = 8.5 
Hz, X part of ABX), 7.35 (dt, J = 7.9 Hz, J = 1.2 Hz, 1H, H4´), 7.26 (1H, dd, H6´, J = 7.9 Hz, J 
= 1.2 Hz), 7.48 (dt, J = 7.9 Hz, J = 1.2 Hz, H5´, 1H), 7.59 (dd, J = 7.9 Hz, J = 1.2 Hz, 1H, H3´), 
8.88 (br s, 1H, NH); 13C NMR (CDCl3) δ 18.5 (CH3-C2), 35.6 (C4), 42.6 (C5), 58.5 (OCH3), 
108.7 (C3), 128.2 (C3´), 129.0 (C4´), 131.2 (C6´), 134.5 (C5´), 139.7 (C1´), 143.8 (C2´), 150.3 
(C2), 167.6 (CO), 201.6 (C6); MS (m/z): 306 (M+), 289. Anal. Calcd for C14H14N2O4S: C, 54.89; 
H, 4.61; N, 9.14. Found: C, 54.83; H, 4.66; N, 9.19. 
Methyl 4-(3’-methoxyphenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5e). Yield 78% (Method A); yellow solid; mp 165-166 °C; 1H NMR (CDCl3) δ 2.46 (s, 3H, 
CH3), 3.19 (d, J = 16.5 Hz, B part of ABX 1H, H5b), 3.37 (dd, J = 16.5 Hz, J = 8.3 Hz, A part of 
ABX 1H, H5a), 3.72 (s, 3H, OCH3), 4.18 (d, J = 8.3 Hz, X part of ABX, 1H, H4), 7.10 (m, 2H, 
H5´, H6’), 7.18 (br s, 1H, H2´), 7.29 (dt, J = 6.3 Hz, J = 2.7 Hz, 1H, H4´), 8.65 (br s, 1H, NH); 
13C NMR (CDCl3) δ 18.6 (CH3-C2), 37.2 (C4), 45.7 (C5), 54.8 (OCH3), 60.5 (OCH3), 112.7 
(C3), 119.8 (C4´), 121.1 (C2´), 124.2 (C5´), δ 129.7 (C6´), 142.9 (C1´), 143.6 (C3´), 159.9 (C2), 
166.5 (CO), 201.4 (C6); MS (m/z): 291 (M+), 259, 229. Anal. Calcd for C15H17NO3S: C, 61.83; 
H, 5.88; N, 4.81. Found: C, 61.79; H, 5.92; N, 4.78. 
Methyl 4-[4’-(methoxycarbonyl)phenyl]-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-
carboxylate (5f). Yield 81% (Method A), 39% (Method B) and 92% (Method C); yellow solid; 
mp 139-141 °C; 1H NMR (CDCl3) δ 2.44 (3H, s, CH3), 2.76 (d, J = 16.5 Hz, B part of ABX, 1H, 
H5b), 3.02 (dd, J = 16.5 Hz, J = 8.3 Hz, A part of ABX, 1H, H5a), 3.62 (s, 3H, OCH3), 3.92 (s, 
3H, OCH3), 4.32 (d, J = 8.3 Hz, X part of ABX, 1H, H4), 7.37 (d, J = 8.3 Hz, 2H, H2´, H6´), 
7.89 (d, J = 8.3 Hz, 2H, H3´, H5´), 8.92 (br s, 1H, NH); 13C NMR (CDCl3) δ 19.3 (CH3-C2), 
36.8 (C4), 45.6 (C5), 52.4 (OCH3), 58.5 (OCH3), 110.7 (C3), 126.5 (C2´, C6´), 128.9 (C4´), 
General Papers  ARKIVOC 2011 (ix) 125-141 
 Page 136 ©ARKAT-USA, Inc. 
130.3 (C3´, C5´),147.5 (C1´), 149.8 (C2), 166.1 (CO), 167.8 (CO), 201.0 (C6); MS (m/z): 319 
(M+), 260, 191. Anal. Calcd for C16H17NO4S: C, 69.17; H, 5.37; N, 4.39. Found: C, 69.22; H, 
5.41; N, 4.32. 
Ethyl 2-methyl-4-phenyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5g). Yield 68% 
(Method A), 30% (Method B) and 87% (Method C); yellowish solid; mp 149-150 °C; 1H NMR 
(CDCl3) δ 2.41 (s, 3H, CH3), 3.09 (d, J = 16.2 Hz, B part of ABX, 1H, H5b), 3.34 (dd, 16.2 Hz, J 
= 7.2 Hz, A part of ABX, 1H, H5a), 3.70 (s, 3H, OCH3), 4.15 (d, J.2 Hz, X part of ABX, 1H, 
H4), 7.02-7.22 (m, 5H, Ph), 8.93 (br s, 1H, NH). 13C NMR (CDCl3) δ 13.9 (CH3CH2), 18.9 
(CH3-C2), 37.5 (C4), 45.3 (C5), 59.7 (OCH2), 110.3 (C3), 126.4 (C4´), 126.9 (C2´, C6´), 128.2 
(C5´), 128.8 (C3´), 140.8 (C1´), 150.9 (C2), 166.8 (CO), 200.3 (C6), MS (m/z): 275 (M+), 229, 
200. Anal. Calcd for C15H17NO2S: C, 65.43; H, 6.22; N, 5.09. Found: C, 65.48; H, 6.18; N, 5.04. 
Ethyl 4-(2’-chlorophenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5h). 
Yield 75% (Method A), 29% (Method B) and 89% (Method C); yellow solid; mp 119-120 °C; 
1H NMR (CDCl3) δ 1.15 (t, J = 7.1 Hz, 3H, CH3), 2.51 (s, 3H, CH3), 3.15 (d, J = 16.3 Hz, B part 
of ABX, 1H, H5b), 3.32 (dd, J = 16.3 Hz, J = 7.7 Hz, A part of ABX, 1H, H5a), 4.12 (m, 2H, 
OCH2), 4.66 (d, J = 7.7 Hz, X part of ABX, 1H, H4), 6.92 (m, 1H, H6´), 7.18 (m, 1H, H4´, H5´), 
7.42 (m, 1H, H3´), 8.92 (br s, 1H, NH); 13C NMR (CDCl3) δ 13.9 (CH3), 18.6 (CH3-C2), 34.3 
(C4), 44.4 (C5), 60.4 (OCH2), 110.6 (C3), 127.0 (C6´), 127.2, 128.3 (C4´, C5´), 130.0 (C3´), 
133.0 (C2´), 138.2 (C1´), 148.0 (C2), 166.1 (CO), 200.8 (C6); MS (m/z): 309 (M+), 274, 236. 
Anal. Calcd for C15H16ClNO2S: C, 58.15; H, 5.21; N 4.52. Found: C, 58.20; H, 5.18; N, 4.56. 
Ethyl 4-(2’,4’-dichlorophenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5i). Yield 77% (Method A); pale yellow solid; mp 155-156 °C; 1H NMR (CDCl3) δ 1.15 (t, J = 
7.1 Hz, 3H,CH3), 2.51 (s, 3H, CH3), 3.15 (d, J = 16.3 Hz, B part of ABX, 1H, H5b), 3.25 (dd, J = 
16.3 Hz, J = 7.9 Hz, A part of ABX, 1H, H5a), 4.05 (m, 2H, OCH2), 4.55 (d, J = 7.9 Hz, X part 
of ABX, 1H, H4), 6.91 (d, J = 8.4 Hz, 1H, H6´), 7.15 (dd, J = 8.4 Hz, J = 2.2 Hz 1H, H5´), 7.45 
(d, J = 2.2 Hz, 1H, H3´), 8.91 (br s, 1H, NH); 13C NMR (CDCl3) δ 14.1 (CH3), 18.6 (CH3-C2), 
34.0 (C4), 46.5 (C5), 60.7 (OCH2), 109.8 (C3), 127.6 (C5´), 128.4 (C3´), 130.1 (C6´), 133.6 
(C4´), 133.9 (C2´), 137.1 (C1´), 148.5 (C2), 166.2 (CO), 200.6 (C6); MS (m/z): 343 (M+), 308, 
270. Anal. Calcd for C15H15Cl2NO2S: C, 52.33; H, 4.39; N, 4.07. Found: C, 52.39; H, 4.43; N, 
4.03. 
Ethyl 2-methyl-4-(2’-nitrophenyl)-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5j). 
Yield 72% (Method A); yellow solid; mp 150-151 °C; 1H NMR (CDCl3) δ 1.22 (t, J = 7.1 Hz, 
3H, CH3), 2.42 (s, 3H, CH3), 3.19 (d, J = 16.6 Hz, B part of ABX, 1H, H5b), 3.35 (dd, J = 16.6 
Hz, J = 8.6 Hz, A part of ABX, 1H, H5a), 4.16 (m, 2H, OCH2), 4.25 (d, J = 8.6 Hz, X part of 
ABX, 1H, H4), 7.25 (m, 1H, H6´), 7.52 (td, J = 7.9 Hz, J = 0.9 Hz, 1H, H4´), 8.02 (m, 1H, H5´), 
8.11 (dd, J = 7.9, J = 0.9 Hz, 1H, H3´), 9.00 (br s, 1H, NH); 13C NMR (CDCl3) δ 14.3 (CH3); 
19.2 (CH3-C2), 37.4 (C4), 45.9 (C5), 61.0 (OCH2), 110.3 (C3), 122.5 (C3´), 127.5 (C6´), 128.3 
(C4´), 130.4 (C5´), 133.2 (C1´), 140.2 (C2´), 148.1 (C2), 166.4 (CO), 200.5 (C6), MS (m/z): 320 
(M+), 247. Anal. Calcd for C15H16N2O4S: C, 56.24; H, 5.03, N 8.74. Found: C, 56.20; H, 5.07; N, 
8.71. 
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Ethyl 2-methyl-4-(3’-nitrophenyl)-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5k). 
Yield 72% (Method A), 32% (Method B) and 91% (Method C); yellow solid; mp 160-161 °C; 
1H NMR (CDCl3) δ 1.05 (t, J = 7.1 Hz, 3H, CH3); 2.33 (s, 3H, CH3), 2.85 (d, J = 16.5 Hz, B part 
of ABX, 1H, H5b),3.14 (dd, J = 16.5 Hz, J = 7.1 Hz, A part of ABX, 1H, H5a), 3.89 (m, 2H, 
OCH2), 4.25 (d, J = 7.1 Hz, X part of ABX 1H, H4), 6.99 (m, 2H, H6´, H5´), 7.24 (br s, 1H, 
H2´), 7.65 (dt, J = 6.5 Hz, J = 2.4 Hz, 1H, H4´), 9.02 (br s, 1H, NH); 13C NMR (CDCl3) δ 14.8 
(CH3), 19.1 (CH3-C2), 37.4 (C4), 44.8 (C5), 60.3 (OCH2), 111.9 (C3), 124.8 (C4´), 125.1 (C2´), 
127.2 (C5´), 130.7 (C6´), 143.5 (C1´), 144.5 (C3´), 150.9 (C2), 166.6 (CO), 200.8 (C6); MS 
(m/z): 320 (M+), 303, 247. Anal. Calcd for C15H16N2O4S: C, 56.24; H, 5.03; N, 8.74. Found: C, 
56.19; H, 4.99; N, 8.70. 
Ethyl 2-methyl-4-(4’-nitrophenyl)-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate (5l). 
Yield 82% (Method A), 36% (Method B) and 93% (Method C); yellow solid; mp 153-154 °C; 
1H NMR (CDCl3) δ 1.05 (t, J = 7.1 Hz, 3H, CH3), 2.33 (s, 3H, CH3), 2.85 (d, J = 16.5 Hz, B part 
of ABX, 1H, H5b), 3.14 (dd, J = 16.5 Hz, J = 7.1 Hz, A part of ABX, 1H, H5a), 3.89 (m, 2H, 
OCH2), 4.25 (d, J = 7.1 Hz, X part of ABX 1H, H4), 7.24 (d, J = 8.7 Hz, 2H, H2´, H6´), 7.75 (d, 
J=8.7 Hz, 2H, H3´, H5´), 8.89 (br s, 1H, NH); 13C NMR (CDCl3) δ 14.8 (CH3), 19.1 (CH3-C2), 
37.2 (C4), 45.8 (C5), 60.3 (OCH2), 110.9 (C3), 124.8 (C4´), 125.1 (C2´), 127.2 (C5´), 130.7 
(C6´), 143.5 (C1´), 144.5 (C3´), 149.9 (C2), 166.6 (CO), 200.8 (C6); MS (m/z): 320 (M+), 303, 
247. Anal. Calcd for C15H16N2O4S: C, 56.24; H, 5.03; N, 8.74. Found: C, 56.21; H, 5.06; N, 
8.72. 
Ethyl 4-(3’-methoxyphenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5m). Yield 81% (Method A), 39% (Method B) and 90% (Method C); yellow solid; mp 157-158 
°C; H1 NMR (CDCl3) δ 1.16 (t, J = 7.0 Hz, 3H, CH3), 2.42 (s, 3H, CH3), 2.91 (d, J = 16.4 Hz, B 
part of ABX, 1H, H5b), 3.09 (dd, J = 16.4 Hz, J = 7.3 Hz, A part of ABX, 1H, H5a), 3.65 (s, 3H, 
CH3O), 3.77 (m, 2H, OCH2), 4.19 (d, J = 7.3 Hz, X part of ABX, 1H, H4), 
 6.69 (m, 1H, H2´), 
6.77 (d, J = 7.7 Hz, 1H, H6´), 6.94 (dd, J = 7.7 Hz, J = 2.1 Hz, 1H, H4´), 7.34 (t, J = 7.7 Hz, 1H, 
H5´), 9.00 (br s, 1H, NH); 13C-NMR (CDCl3) δ 14.7 (CH3), 19.2 (CH3-C2), 37.6 (C4), 44.7 (C5), 
53.9 (OCH3), 59.8 (OCH2), 111.4 (C4´), 112.0 (C3), 115.1 (C2´), 118.9 (C6´), 129.7 (C5´), 141.5 
(C1´), 149.4 (C3´), 151.7 (C2), 166.7 (CO), 201.6 (C6); MS (m/z): 305 (M+), 259, 231. Anal. 
Calcd for C16H19NO3S: C, 62.93; H, 6.27; N, 4.59. Found: C, 62.98; H, 6.30; N, 4.62. 
Ethyl 4-(4’-methoxyphenyl)-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5n). Yield 76% (Method A); yellow solid; mp 146-147 °C; H1 NMR (CDCl3) δ 1.13 (t, J = 7.0 
Hz, 3H, CH3), 2.51 (s, 3H, CH3), 2.89 (d, J = 16.3 Hz, B part of ABX, 1H, H5b), 3.19 (dd, J = 
16.3 Hz, J = 7.1 Hz, A part of ABX, 1H, H5a), 3.70 (s, 3H, CH3O), 3.92 (m, 2H, OCH2), 4.21 (d, 
J = 7.1 Hz, X part of ABX, 1H, H4), 7.04 (d, J = 8.5 Hz, 2H, H2´, H6´), 7.74 (d, J = 8.5 Hz, 2H, 
H3´, H5´), 8.91 (br s, 1H, NH); 13C NMR (CDCl3) δ 14.1 (CH3), 18.6 (CH3-C2), 34.0 (C4), 44.5 
(C5), 52.1 (OCH3), 60.7 (OCH2), 109.8 (C3), 127.6 (C3´, C5´), 128.4 (C1´), 130.1 (C2´, C6´), 
137.1 (C4´), 144.5 (C2), 166.2 (CO), 200.6 (C6); MS (m/z): 305 (M+), 259, 231. Anal. Calcd for 
C16H19NO3S: C, 62.93; H, 6.27; N, 4.59. Found C, 62.88; H, 6.32; N, 4.64. 
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Ethyl 4-[4’-(methoxycarbonyl)phenyl]-2-methyl-6-thioxo-1,4,5,6-tetrahydropyridine-3-
carboxylate (5o). Yield 74% (Method A), 39% (Method B) and 88% (Method C); yellow solid; 
mp 167-168 °C; H1 NMR (CDCl3) δ 1.12 (t, J = 7.0 Hz, 3H, CH3), 2.45 (s, 3H, CH3), 3.12 (d, J = 
16.4 Hz, B part of ABX, 1H, H5b), 3.31 (dd, J = 16.4 Hz, J = 7.3 Hz, A part of ABX, 1H, H5a), 
3.91 (s, 3H, CH3O), 4.08 (m, 2H, OCH2), 4.18 (d, J = 7.3 Hz, X part of ABX, 1H, H4), 7.20 (d, J 
= 8.3 Hz, 2H, H2´, H6´), 7.92 (d, J = 8.3 Hz, 2H, H3´, H5´), 9.18 (br s, 1H, NH); 13C NMR 
(CDCl3) δ 14.7 (CH3), 18.7 (CH3-C2), 37.4 (C4), 45.8 (C5), 52.0 (OCH3), 60.5 (OCH2), 110.4 
(C3), 126.9 (C3´, C5´), 128.9 (C4´), 130.0 (C2´, C6´), 143.3 (C1´), 146.9 (C2), 166.3 (CO), 
166.7 (CO), 200.7 (C6); MS (m/z): 333 (M+), 287, 260, 228. Anal. Calcd for C17H19NO4S: C, 
61.24; H, 5.74; N, 4.20. Found: C, 61.29; H, 5.77; N, 4.26. 
Ethyl 2-methyl-4-(pentafluorophenyl)-6-thioxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5p). Yield 64% (Method A), 35% (Method B) and 87% (Method C); yellow pale solid; mp 132-
133 °C; 1H NMR (CDCl3) δ 1.18 (t, J = 7.2 Hz, 3H, CH3), 2.45 (3H, s, CH3), 2.89 (d, J = 16.6 
Hz, B part of ABX, 1H, H5b), 3.22 (dd, J = 16.6 Hz, J = 10.2 Hz, A part of ABX, 1H, H5a), 4.10 
(m, 2H, OCH2), 4.52 (d, J = 10.2 Hz, X part of ABX, 1H, H4), 8.82 (br s, 1H, NH); 
13C NMR 
(CDCl3) δ 15.1 (CH3), 19.0 (CH3-C2), 27.9 (C4), 43.6 (C5), 60.33 (OCH2), 116.2 (C3), 136.2 
(C3´, C5´), 141.4 (C1´), 143.8 (C4´), 144.8 (C2´, C6´), 146.3 (C2), 166.9 (CO), 199.1 (C6), MS 
(m/z): 366 (M+), 334, 207. Anal. Calcd for C15H12F5NO2S: C, 42.32; H, 3.31; N, 3.83. Found: C, 
42.38; H, 3.35; N, 3.79. 
 
 
Acknowledgements     
 
The part of this work carried out in Barcelona was partially supported by CICYT (CTQ2009-
07758), the Generalitat de Catalunya (2009SGR 1024), the Institute for Research in 
Biomedicine, and the Barcelona Science Park. This work was also supported by the MICINN of 
Spain (project CT2008-00795/BQU and Consolider-Ingenio 2010C-07-25200). 
 
 
References    
 
1. (a) Konaklieva, M. I.; Plotkin, B. J. Recent Patents on Anti-Infective Drug Discovery 2006, 1, 
177. (b) Rezanka, T.; Sobotka, M.; Spizek, J.; Sigler, K. Anti-Infective Agents in Medicinal 
Chemistry 2006, 5, 187. (c) Skala, P.; Machacek, M.; Vejsova, M.; Kubicova, L.; Kunes, J.; 
Waisser, K. J. Heterocycl. Chem. 2009, 46, 873. (d) Nagawade, R. R.; Shinde, D. B. J. 
Heterocycl. Chem. 2010, 47, 33. (e) Padmaja, A.; Payani, T.; Reddy, G. Dinneswara; 
Padmavathi, V. Eur. J. Med. Chem. 2009, 44, 4557. (f) Peters, R. H.; Crowe, D. F.; Avery, 
M. A.; Chong, W. K. M.; Tanabe, M. J. Med. Chem. 1988, 32, 1642. 
2. Segura, J. L.; Martín, N. Angew. Chem., Int. Ed. 2001, 40, 1372. (b) Herranz, M.; Sanchez, 
L.; Martin, N. Phosp. Sulfur & Silicon and the Related Elements 2005, 180, 1133. 
General Papers  ARKIVOC 2011 (ix) 125-141 
 Page 139 ©ARKAT-USA, Inc. 
3. (a) Krauze, A.; Duburs, G. Chem. Heterocycl. Comp. 2000, 36, 693. (b) Das, B.; Srivastava, 
S.; Sarvanan, J.; Mohan, S. Asian J. Chem. 2007, 19, 4118. 
4. (a) Barthakur, M. G.; Chetia, A.; Boruah, R.C. Tetrahedron Lett. 2006, 47, 4925. (b) 
Balalaie, S.; Bararjanian, M.; Rominger, F. J. Heterocycl. Chem. 2006, 43, 821. (c) 
Shigetomi, T.; Soejima, H.; Nibu, Y.; Shioji, K.; Okuma, K.; Yokomori, Y. Chem. Eur. J. 
2006, 12, 7742. 
5. Krauze, A.; Vitolinya, R. O.; Romanova, M. R.; Dubur, G. Khim.-Farm. Zh. 1988, 22, 548. 
6. Krauze, A.; Odynets, A. G.; Verreva, A.; Germane, S.; Kozhukhov, A. N.; Dubur, G. Khim.-
Farm. Zh. 1991, 25, 40. 
7. Kirule, I. E.; Krauze, A.; Velena, A. Kh.; D. Antipova, Yu.; Amitsane, G. Ya.; Vutsina, A.; 
Dubur, G. Khim.-Farm. Zh. 1992, 26, 59. 
8. (a) Krauze, A.; Baumane, L.; Sile, L.; Chernova, L.; Vilums, M.; Vitolina, R.; Duburs, G.; 
Stradins, J. Chem. Heterocycl. Comp. 2004, 40, 876. (b) Baumane, L.; Krauze, A.; Belyakov, 
S.; Sile, L.; Chernova, L.; Griga, M.; Duburs, G.; Stradis, J. Chem. Heterocycl. Comp. 2005, 
41, 362. (c) A.M. Shestopalov, L. A. Rodinovskaya, A. A. Shestopalov J. Comb. Chem. 
2010, 12, 9. 
9. (a) Fenniri, H. Combinatorial Chemistry; Oxford University Press: New York, 2000. (b) 
Seneci, P. Solid-Phase Synthesis and Combinatorial Technologies; John Wileys & Sons: 
New York, 2000. 
10. Gedye, R.; Smith, F.; Westaway, K.; Ali, H.; Baldisera, L.; Laberge, L.; Rousell, J. 
Tetrahedron Lett. 1986, 27, 279. 
11. Giguere, R. J.; Bray, T. L.; Duncan, S. M.; Majetich, G. Tetrahedron Lett. 1986, 27, 4945. 
12. (a) Kappe, C. O.; Dallinger D. Mol Divers 2009 13, 71. (b) Jiang, B.; Shi, F.; Tu, S. J., 
Current Organic Chemistry, 2010, 14, 357. 
13. (a) Kappe, C. O.; Dallinger, D. Nat. Rev. Drug Discov., 2006, 5, 51. (b) Santagada, V.; 
Frecentese, F.; Perissutti, E.; Favretto, L.; Caliendo, G. QSAR Comb. Sci. 2004, 23, 919. (c) 
Katritzky, A. R.; Singh, S. K. Curr. Top. Med. Chem. 2004, 4, 773. (d) Suna, E.; Mutule, I. 
Top. Current Chem. 2006, 266, 49. 
14. (a) Rodríguez, H.; Martín, O.; Ochoa, E.; Suárez, M.; Reyes, O.; Garay, H.; Albericio, F.; 
Martín, N. QSAR Comb. Sci. 2006, 25, 921. (b) Álvarez, A.; Suárez, M.; Verdecia, Y.; 
Ochoa, E.; Barried, B.; Pérez, R.; Díaz, M.; Martínez, R.; Molero, D.;  Seoane, C.; Novoa, 
H.; Blaton, N.; Peeters, O. M.; Martín, N. Heterocycles 2006, 68, 1631. (c) Suárez, M.; 
Novoa, H.; Verdecia, Y.; Ochoa, E.; Álvarez, A.; Pérez, R.; Martínez, R.; Molero, D.; 
Seoane, C.; Blaton, N.; Peeters, O. M.; Martín, N. Tetrahedron 2006, 62, 1365. (d) Suárez, 
M.; Álvarez, A.; de Armas, M.;  Ramírez, O.; Martínez, R.; .Liz, R.; Martín, N. New J. 
Chem. 2005, 29, 1567. (e) Suárez, M.; Verdecia, Y.; Illescas, B.; Martín, N.; Martínez, R.; 
Ochoa, E.; Álvarez, A.; Seoane, C.; Tetrahedron 2003, 59, 9179. (f) Suárez, M.; Verdecia, 
Y.; Ochoa, E.; Martín, N.; Seoane, C.; Martínez, R.; Novoa, H.; Peeters, O. M.; Blaton, N. J. 
Heterocycl. Chem. 2003, 40, 269. (g) Novoa, H.; Blaton, N.; Peeters, O. M.; De Ranter, C. J.; 
General Papers  ARKIVOC 2011 (ix) 125-141 
 Page 140 ©ARKAT-USA, Inc. 
Rolando, E.; Ochoa, E.; Verdecia, Y.; Martín, N.; Quinteiro, M.; Seoane, C.; Soto, J. L. J. 
Heterocycl. Chem. 2000, 37, 1575. 
15. (a) Kuznetsov, D. V.; Raev, V. A.; Kuranov, G. L.; Arapov, O. V.; Kostikov, R. R. Russ. J. 
Org. Chem., 2005, 12, 1719. (b) Herrero, M.A.; Kremsner, J. M.; Kappe, C. O. J. Org. Chem. 
2008, 73, 36. (c) Polshettiwar, V.; Varma, R. S. Accounts of Chem. Res. 2008, 41, 5, 629. 
16. (a) Skala, P.; Machacek, M.; Vejsova, M.; Kubicova, L.; Kunes, J.; Waisser, K. J. 
Heterocycl. Chem. 2009, 46, 873. (b) Rao, Y.; Xuechen, L.; Nagorny, P.; Hayashida, J.; 
Danishefsky, S. J. Tetrahedron Lett. 2009, 50, 6684. (c) Seijas, J. A.; Vazquez-Tato, M.; 
Crecente-Campo, J. Tetrahedron 2008, 64, 9280. (d) Saeed, A.; Ashraf, Z. J. Heterocycl. 
Chem. 2008, 45, 679. (e) Barthakur, G.; Chetia, A.; Boruah, R. C. Tetrahedron Lett. 2006, 
47, 4925. (f) Qiuping, D.; Huang, X. G.; Wu, J. J. Comb. Sci. 2009, 11, 1047. 
17. (a) Jesberger, M.; Davis, T. P.; Barner, L. Synthesis 2003, 13, 1929. (b) Przychodzen, W. 
Eur. J. Org. Chem. 2005, 2002. (c) Przychodzen, W. Heteroatom Chem. 2006, 17, 676. 
18. Rodríguez, H.; Suárez, M.; Pérez, R.; Petit, A.; Loupy, A. Tetrahedron Lett. 2003, 44, 3709. 
19. Lawesson, S.O.; Perregaard, J.; Scheibye, S.; Meyer, H. J.; Thomsen, I. Bull. Soc. Chim. 
1977, 86, 679. 
20. (a) Rao Y.; Li X.; Nagorny, P.; Hayashida, J.; Danishefsky, S.J. Tetrahedron Lett. 2009, 50, 
6684. (b) Jayanthi P.; Lalitha, P.; Sripathi, S. K. Asian J. Exp. Sci. 2009, 23, 123. 
21. Cava, M. P.; Levinson, M. I. Tetrahedron 1985, 41, 5061. 
22. Perreux, L.; Loupy, A. Tetrahedron 2001, 57, 9199. 
23. (a) Verdecia, Y.; Suárez, M.; Morales, A.; Rodríguez, E.; Ochoa, E.; González, L.; Martin, 
N.; Quinteiro, M.; Seoane, C.; Soto, J. L. J. Chem. Soc., Perkin Trans. 1 1996, 947. (b) 
Molero, D.; Suárez, M.; Martínez-Alvarez, R.; Verdecia, Y.; Martin, N.; Seoane, C.; Ochoa, 
E. Magn. Reson. Chem. 2004, 42, 704. 
24. (a) Suárez, M.; Martínez-Álvarez, R.; Martin, N.; Verdecia, Y.; Ochoa, E.; Alba, L.; Seoane, 
C.; Kayali, N. Rapid Commun. Mass Spectrom. 2002, 16, 749. (b) Morales, A.; Ochoa, E.; 
Suarez, M.; Verdecia, Y.; González, L.; Martín, N.; Quinteiro, M.; Seoane, C.; Soto, J. L. J. 
Heterocycl. Chem. 1996, 33, 103. 
25. (a) Ochoa, E.; Suarez, M., Verdecia, Y., Pita, B.; Martin, N.; Quinteiro, M., Seoane, C.; Soto, 
J. L.; Duque, J.; Pomes, R. Tetrahedron 1998, 54, 12409. (b) Suárez, M.; Ochoa, E.; 
Verdecia, Y.; Pita, B.; Moran, L.; Martín, N.; Quinteiro, M.; Seoane, C.; Soto, J. L.; Novoa, 
H.; Blaton, R.; Peeters, O. M.; De Ranter, C. J. Eur. J. Org. Chem. 2000, 2079. (c) Duque, J.; 
Pomés, R.; Suárez, M.;  Verdecia, Y.; Ochoa, E.; Pita, B. Acta Cryst. 1998, C54, 1642. 
26. Triggle, D. J. Mini Rev. Med. Chem. 2003, 3, 215. 
27. (a) Lavilla, R. J. Chem. Soc., Perkin Trans. 1 2002, 1141. (b) Triggle, D. J. Cell. Mol. 
Neurobiol. 2003, 23, 293. 
28. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. 
R.; Zakrzewski, V. G.; Montgomery, J. A.; Stratmann, Jr., R. E.; Burant, J. C.; Dapprich, S.; 
Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, 
V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; 
General Papers  ARKIVOC 2011 (ix) 125-141 
 Page 141 ©ARKAT-USA, Inc. 
Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; 
Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. 
B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. 
J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; González, C.; Challacombe, 
M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; González, C.; Head-
Gordon, M.; Replogle, E. S.; Pople, J. A. GAUSSIAN 98 (Revision A.37), Gaussian, Inc.. 
Pittsburgh, PA, 1998. 
 
 
